 Insulin receptor is expressed in both rat and human central amygdala.  Insulin enhances GABA-mediated phasic inhibition in rat central amygdala neurons. 
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A C C E P T E D M
A N U S C R I P T
Introduction
The pancreatic hormone, insulin, enters the central nervous system via several putative routes [1] . It binds to the insulin receptor widely distributed in brain regions such as hypothalamus and hippocampus, and exerts diverse actions including regulation of energy homeostasis and cognitive functions [2, 3] . Several lines of emerging evidence indicate that defective brain insulin signaling leads to increased food intake, hypothermia, hypothalamic hypogonadism and blunted response to hypoglycemia [4] [5] [6] . In addition, brain insulin resistance has been associated with cognitive impairments in type 2 diabetes, neurodegenerative diseases and mood disorders [7] [8] [9] .
A key brain region connecting emotion/mood with control of food intake is the amygdala. The amygdala is located in the mid temporal lobe and best known for regulating emotional reactivity, such as fear and anxiety [10] . Furthermore, recent findings suggest that the amygdala integrates sensory and hormonal stimuli, interacts with various cortical and subcortical regions including hypothalamus, striatum, hippocampus and cortex, modulating feeding behavior [11] . Indeed, the amygdala expresses receptors for several metabolic hormones including insulin and leptin [12] [13] [14] . In addition, application of different metabolic hormones to the amygdala in animals affects food intake and results in anxiety-like behaviors [14, 15] . Functional magnetic resonance imaging (fMRI) studies in humans have also shown the modulation of amygdala activities after administration of hormones such as ghrelin [16, 17] . However, the neuronal pathways underlying these effects are not fully understood.
The central nucleus of the amygdala (CeA) is the main output station of the amygdala and sends out efferent projections to various brain areas to coordinate physiological and behavioral responses [18, 19] . Injection of insulin directly to the CeA produces potent anorectic effect and short-term high fat diet can induce amygdala insulin resistance in rats [15] . However, how insulin regulates the neural transmission in the CeA has been largely unexplored. The predominant neuronal type in the CeA is GABAergic (-aminobutyric acid) projection neurons that receive both glutamatergic and GABAergic innervations from other subdivisions of amygdala as well as other brain areas [20] . CeA projection neurons express GABAA receptors (GABAARs) that mediate phasic and tonic inhibition regulating neuronal excitability and neuronal networks [21, 22] . GABA-activated phasic inhibition involves fast spontaneous postsynaptic currents (sIPSCs), whereas tonic inhibition is carried by persistent inhibitory currents via activation of high-affinity extrasynaptic GABAARs. It has been shown that acute ethanol exposure modulates both GABAAR mediated phasic and tonic inhibition in a subpopulation of CeA neurons in mice [22] . In hippocampal CA1 neurons, insulin enhances both synaptic and tonic currents by increasing the membrane insertion of synaptic GABAAR and turning on extrasynaptic GABAAR, respectively [23, 24] . Since insulin exerts distinct actions in different brain regions, it is intriguing to investigate if insulin modulates these two types of GABA-activated neuronal inhibition mechanisms in CeA neurons.
In the current study we first sought to examine the mRNA expression and protein distribution of the insulin receptor in the CeA and further explored the effect of insulin on GABAAR-mediated neuronal inhibition in rat CeA neurons.
Materials and Methods
A C C E P T E D M A N U S C R I P T
Animals
Wistar rats aged 16-22 days and 2-month old C57BL/6 mice were used in all experiments. All animal experiments were carried out in accordance with the local ethical guidelines and protocols approved by the Uppsala Animal Ethical Board (Uppsala, Sweden).
Rat brain slice preparation
Animals was decapitated and brains were rapidly removed and immersed into an icecold artificial cerebrospinal fluid (aCSF) comprising (in mM): 124 NaCl, 3 KCl, 2.5 CaCl2, 1.3 MgSO4, 26 NaHCO3, 2.5 Na2HPO4, and 10 glucose, 300 mOsm, pH 7.3-7.4 when bubbled with 95% O2 and 5% CO2. Coronal brain sections, 400 m thick, were prepared with a vibratome (Leica VT1200, Leica, Germany) in the ice-cold aCSF. Slices were recovered in the same aCSF at 34 o C for at least half an hour and then kept at room temperature (20) (21) (22) o C) until used in experiments.
Reverse-Transcription Quantitative PCR (RT-qPCR)
The central amygdala and hippocampus were isolated from rat coronal brain sections.
Post-mortem human brain samples from the CeA and hippocampal dentate gyrus were obtained at the New South Wales Tissue Resource Center (TRC), University of Sydney, Australia (http://sydney.edu.au/medicine/pathology/trc/index.php) [25, 26] .
Total RNA was extracted using GenElute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, Germany) and quantified with Nanodrop (Thermo Scientific, USA).
Total RNA was further reverse transcribed to cDNA using SuperScript II reverse transcriptase (Thermo Scientific, USA) in a 20 μl reaction. RT negative control was also run in parallel by omitting reverse transcriptase in the RT reaction in order to examine the possible genomic DNA contamination in the extracted RNA sample.
Real-time quantitative PCR was performed using ABI PRISM 7900HT Sequence Detection System (Thermo Scientific, USA) as previously described [25] . 
Immunofluorescence staining and confocal microscopy
Rat and mouse coronal brain sections (1-2 mm thick), were prepared using Vibratome (Leica VT1200, Leica, Germany) as described above and fixed in 4% paraformaldehyde for 1 hour on ice. Sections were washed twice with 0.1 M phosphate buffer (PB, pH 7.4) and immersed in 30% sucrose overnight. Cryosections of 14 m of thickness were prepared using a cryostat (Leica, Germany), washed with 0.1 M phosphate buffered saline (PBS, pH 7.4) and blocked in a blocking solution
containing 10% normal donkey serum, 0.2% bovine serum albumin and 0.2% Triton X-100) for 1 hour at room temperature. Cryosections were further incubated with the primary antibody rabbit anti-insulin receptor (IRβ C19, 1:100, Santz Cruz, sc-711, Germany) overnight at 4 °C followed by incubation with donkey anti-rabbit Alexafluor 488 (1:500, Jackson Laboratory, USA) for 1 hour at room temperature. The images were acquired using LSM700 confocal microscopy (Zeiss, Germany).
Negative controls included omission of primary antibody incubation or pre-block the primary antibody with blocking peptides (1:5) before applying to the sections. Both controls resulted in no detectable staining. The anti-insulin receptor antibody (IRβ C19) is an affinity purified rabbit polyclonal antibody raised against peptide sequence mapping at the C-terminus of human insulin receptor β subunit (NCBI accession number P06213), which is also conserved in rat and mouse. The epitope does not show sequence similarity with human insulin-like growth factor 2 receptor (IGF2R, NCBI accession number NP_00867). This antibody does not cross-react with insulinlike growth factor 1 receptor (IGF1R) [27, 28] . The specificity of IRβ C19 antibody has been validated by Western blot and immunofluorescence staining in mice that lack insulin receptor expression in the brain (e.g. NIRKO mice) [29] .
Whole-cell patch-clamp recording and analysis
Whole-cell voltage-clamp recordings were performed at room temperature as previously described [24, 30] . All drugs including insulin and GABAAR antagonist bicuculline methbromide were purchased from Sigma-Aldrich (Germany). Insulin stock solution was prepared by dissolving insulin powder in diluted hydrochloric acid.
Bicuculline methobromide was dissolved in water as a stock solution. All stock solutions were further diluted in aCSF containing kynurenic acid (3 mM) to the final working concentration. The aCSF containing kynurenic acid (3 mM) plus other drugs 
Statistical analysis
Statistical analysis was performed using GraphPad Prism 7 software. Data were presented as mean ± standard error of the mean (SEM 
Results

A C C E P T E D M
Expression of insulin receptor mRNA and protein in the central amygdala neurons
To determine whether insulin receptor mRNA is present in the central amygdala, the hippocampus, that is known to abundantly express the insulin receptor, was used as an internal positive control. RT-qPCR was performed with insulin receptor specific primer pairs in samples from rat hippocampus and central amygdala. The presence of insulin receptor mRNA in the rat central amygdala was confirmed by the same peak in the melting curve and same size of band in the agarose gel as detected from hippocampal samples (data not shown). There was no significant difference in the expression level of insulin receptor mRNA between central amygdala and hippocampal samples (Fig. 1A) . We also detected the expression of insulin receptor mRNA in the central amygdala and hippocampal dentate gyrus from post-mortem human brain samples (Fig. 1B) .
We further examine the localization of insulin receptor in the rat and mouse central amygdala. Brain sections that were incubated with an antibody against the insulin receptor showed abundant fluorescent staining throughout the central amygdala region, as well as in hippocampal CA1 pyramidal neurons that were used as an additional positive control of antibody specificity (Fig. 1C) . A high percentage of neuronal cell bodies in the central amygdala displayed insulin receptor-like immunoreactivity, although the precise numbers were not evaluated quantitatively.
Pre-block insulin receptor antibody (IRβ C19) with blocking peptide (1:5) abolished insulin receptor-like immunoreactivity in mouse CeA neurons.
Insulin enhances GABA-activated spontaneous inhibitory postsynaptic currents (sIPSCs) in rat central amygdala neurons
We have previously shown that insulin at physiologically relevant concentration selectively enhances GABAAR-mediated neuronal inhibition in rat hippocampal CA1
neurons [24] . Here we examined the effect of insulin on GABA-activated inhibitory currents in rat central amygdala neurons. The GABAAR-mediated whole-cell currents were recorded in rat brain slices perfused with aCSF containing kynurenic acid.
Insulin (5 or 50 nM) was applied to the recorded neuron and at the end of each experiment the GABAAR specific antagonist bicuculline (100 µM) was added to inhibit the GABA-activated currents.
Representative current traces from a central amygdala neuron show that the application of 5 nM insulin enhanced the sIPSCs ( Fig. 2A) . The amplitude of sIPSCs detected in 2-min recordings was significantly increased during insulin application as compared to that in aCSF control condition in the same neuron (Fig. 2B) , whereas inter-sIPSC event intervals were decreased (related to sIPSC frequency increase) in the presence of insulin (Fig. 2B) . The application of 50 nM insulin to central amygdala neurons produced similar enhancement of sIPSC amplitudes and frequency as observed for 5 nM. We, therefore, combined the data at both concentrations for analysis. The potentiation of sIPSCs by insulin usually took 5-10 min after the insulin application to reach the maximal effect. The mean sIPSC frequency increased from 1.7±0.31 Hz in aCSF to 2.75±0.61 Hz during insulin application (Fig. 2C ). In addition, the average amplitude of sIPSCs increased in the presence of insulin from 58.8±7.2 to 70.9±10.4 pA (Fig. 2C, n=8 , paired t-test, p<0.05). We also examined the effect of insulin on the GABAAR-mediated tonic current in the neurons. There was no significant change of tonic current amplitude before and after insulin application 
Discussion
In the present study we first validated the central nucleus of the amygdala as a target for insulin by demonstrating the presence of the insulin receptor mRNA and protein in the rat CeA neurons. We further performed whole-cell patch-clamp studies on CeA neurons in acute rat brain slices and found that relevant concentration of insulin selectively enhanced GABAAR-mediated synaptic currents but had no apparent effects on tonic currents in CeA neurons. Thus, the GABAergic synapse could be an important target for insulin action in the CeA.
The multiple actions of insulin in the brain are mediated via the insulin receptors that are abundantly expressed in many brain regions including the hypothalamus and hippocampus. In recent years, the role of hippocampal insulin receptor signaling in cognitive function has been extensively investigated in both human and animal studies [31, 32] . Thus, we have used rat hippocampal tissue as an internal control for the detection of insulin receptor in the CeA. Our quantitative PCR results demonstrate the expression level of insulin receptor mRNA is similar in rat hippocampus and CeA, which is consistent with findings from an early study using in vitro receptor autoradiography assay [33] . A subsequent immunohistochemcal study revealed widespread expression of insulin receptor in all regions of rat amygdala [13] . Our immunofluorescent staining data further confirmed the presence of dense insulin receptor-like immunoreactivities in the soma of the majority of CeA neurons. There are two major types of neurons with different morphological and electrophysiological properties, which are homogeneously distributed throughout the rat CeA [34] . If GABAAR from/to the cell membrane [38, 39] . Therefore, it is of interest to further investigate if insulin-enhancing effect on sIPSCs in rat CeA is caused by pre-or postsynaptic mechanism or both. It has been well documented that receptors for various neuropeptides and hormones are distributed in the CeA and the activation of these receptors could modulate the neurotransmission within the CeA microcircuitry [18] .
For example, corticotropin releasing factor (CRF) acts on CRF receptor-1 (CRF1)-expressing neurons and enhances GABA release in the CeA of rats [40] . These CRF1-containing neurons exhibit intrinsic α1 subunit containing GABAAR-mediated tonic conductance [22] . In contrast, we have not detected GABA-activated tonic current in the CeA neurons even when insulin was applied, which indicates they are less likely to be CRF1-expressing neurons.
CONCLUSION
The CeA is a heterogeneous structure and has extensive afferent and efferent connections within the amygdala as well as other brain regions such as hypothalamus, striatum and hippocampus. Animal behavioral studies suggest that the potential role of CeA response to hormone stimulus is related to emotion-related memory and regulation of food intake under physiological and pathophysiological conditions [14, 15] . Our findings further reveal that the GABAergic synaptic transmission is a target for insulin in the CeA. However, future studies are needed to characterize the specific hormone-responding neuronal populations in the CeA and their participation in circuitry governing the distinct behaviors. 
